...
首页> 外文期刊>Wiley Interdisciplinary Reviews. Developmental Biology >Bone Marrow, Adipose, and Lung Tissue-Derived Murine Mesenchymal Stromal Cells Release Different Mediators and Differentially Affect Airway and Lung Parenchyma in Experimental Asthma
【24h】

Bone Marrow, Adipose, and Lung Tissue-Derived Murine Mesenchymal Stromal Cells Release Different Mediators and Differentially Affect Airway and Lung Parenchyma in Experimental Asthma

机译:骨髓,脂肪和肺组织衍生的小鼠间充质基质细胞释放不同的介质,并在实验性哮喘中差异影响气道和肺部牙科

获取原文
获取原文并翻译 | 示例
           

摘要

Mesenchymal stromal cells (MSCs) from different sources have differential effects on lung injury. To compare the effects of murine MSCs from bone marrow (BM), adipose tissue (AD), and lung tissue (LUNG) on inflammatory and remodeling processes in experimental allergic asthma, female C57BL/6 mice were sensitized and challenged with ovalbumin (OVA) or saline (C). Twenty-four hours after the last challenge, mice received either saline (50 mu l, SAL), BM-MSCs, AD-MSCs, or LUNG-MSCs (10(5) cells per mouse in 50 mu l total volume) intratracheally. At 1 week, BM-MSCs produced significantly greater reductions in resistive and viscoelastic pressures, bronchoconstriction index, collagen fiber content in lung parenchyma (but not airways), eosinophil infiltration, and levels of interleukin (IL)-4, IL-13, transforming growth factor (TGF)-beta, and vascular endothelial growth factor (VEGF) in lung homogenates compared to AD-MSCs and LUNG-MSCs. Only BM-MSCs increased IL-10 and interferon (IFN)-gamma in lung tissue. In parallel in vitro experiments, BM-MSCs increased M2 macrophage polarization, whereas AD-MSCs and LUNG-MSCs had higher baseline levels of IL-4, insulin-like growth factor (IGF), and VEGF secretion. Exposure of MSCs to serum specimens obtained from asthmatic mice promoted reductions in secretion of these mediators, particularly in BM-MSCs. Intratracheally administered BM-MSCs, AD-MSCs, and LUNG-MSCs were differentially effective at reducing airway inflammation and remodeling and improving lung function in the current model of allergic asthma. In conclusion, intratracheal administration of MSCs from BM, AD, and LUNG were differentially effective at reducing airway inflammation and remodeling and improving lung function comparably reduced inflammation and fibrogenesis in this asthma model. However, altered lung mechanics and lung remodeling responded better to BM-MSCs than to AD-MSCs or LUNG-MSCs. Moreover, each type of MSC was differentially affected in a surrogate in vitro model of the in vivo lung environment.
机译:来自不同来源的间充质基质细胞(MSCs)对肺损伤具有差异影响。为了将鼠MSCs从骨髓(BM),脂肪组织(AD)和肺组织(肺)对实验过敏性哮喘中的炎症和重塑过程中的影响进行比较,雌性C57BL / 6小鼠敏化并用卵酸酯(OVA)攻击或盐水(c)。最后一次挑战后二十四小时,小鼠接受盐水(50μL,SAL),BM-MSC,AD-MSC或肺部MSC(每只小鼠10(5)个细胞以50μl总体积)的肺部肿瘤。在1周,BM-MSCs在肺实质(但不是航空公司),嗜酸性粒细胞浸润和白细胞介素(IL)-4,IL-13的水平,转化与Ad-MSC和肺部MSCs相比,肺匀浆中生长因子(TGF)-Beta和血管内皮生长因子(VEGF)。只有BM-MSCs增加IL-10和干扰素(IFN)-Gamma在肺组织中。在平行体外实验中,BM-MSCs增加了M2巨噬细胞极化,而Ad-MSC和肺MSCs具有更高的IL-4,胰岛素样生长因子(IGF)和VEGF分泌的基线水平。 MSCs暴露于从哮喘小鼠获得的血清样品促进这些介质分泌的降低,特别是在BM-MSC中。肿瘤内施用的BM-MSCs,Ad-MSC和肺部MSC在减少气道炎症和改良的过敏性哮喘模型中的减少气道炎症和改善肺功能时差异有效。总之,来自BM,AD和肺的腹腔内施用MSCs在减少气道炎症和改造中的差异有效,并且改善肺功能在该哮喘模型中具有相对降低的炎症和纤维发生。然而,改变的肺部力学和肺重塑对BM-MSCs的反应比Ad-MSC或肺部MSCs更好。此外,每种类型的MSC在体内肺环境中的替代体外模型中差异地影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号